These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36532085)

  • 1. How does China's stock market react to supply chain disruptions from COVID-19?
    Wang Z; Dong Y; Liu A
    Int Rev Financ Anal; 2022 Jul; 82():102168. PubMed ID: 36532085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evidence on the impact of the COVID-19 outbreak and vaccine discovery on the global transportation industry.
    Maneenop S; Kotcharin S
    Transp Res Interdiscip Perspect; 2023 Jan; 17():100741. PubMed ID: 36618962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial performance of China's listed firms in presence of coronavirus: Evidence from corporate culture and corporate social responsibility.
    Zheng F; Zhao Z; Sun Y; Khan YA
    Curr Psychol; 2023; 42(11):8897-8918. PubMed ID: 34400856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of the COVID-19 Pandemic on Consumer Behavior-Evidence From China's Stock Market.
    Lu Z; Zhu L; Li X; Li Z
    Front Public Health; 2022; 10():865470. PubMed ID: 36148367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The time-varying spillover effect of China's stock market during the COVID-19 pandemic.
    Liu X; Chen Z; Chen Z; Yao Y
    Physica A; 2022 Oct; 603():127821. PubMed ID: 35782685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spillover effects of China's regional environmental markets to local listed firms: a risk Granger causality approach.
    Zhu S; Tang Y; Qiao X; Peng C; Li D
    Environ Sci Pollut Res Int; 2020 Dec; 27(35):44123-44136. PubMed ID: 32761345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and financial market response in China: Micro evidence and possible mechanisms.
    Wang Z; Zhang Z; Zhang Q; Gao J; Lin W
    PLoS One; 2021; 16(9):e0256879. PubMed ID: 34499691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19 and economic policy uncertainty on China's stock market returns: evidence from quantile-on-quantile and causality-in-quantiles approaches.
    Ullah A; Zhao X; Amin A; Syed AA; Riaz A
    Environ Sci Pollut Res Int; 2023 Jan; 30(5):12596-12607. PubMed ID: 36109486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When does digital merger and acquisition create shareholder value? An empirical investigation in the Chinese context.
    Huang G; Shen L
    Heliyon; 2024 Jul; 10(14):e34237. PubMed ID: 39092241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus disease outbreak and supply chain disruption: Evidence from Taiwanese firms in China.
    Tang CH; Chin CY; Lee YH
    Res Int Bus Finance; 2021 Apr; 56():101355. PubMed ID: 33731971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESG performance and stock prices: evidence from the COVID-19 outbreak in China.
    Li Z; Feng L; Pan Z; Sohail HM
    Humanit Soc Sci Commun; 2022; 9(1):242. PubMed ID: 35874283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does CSR performance improve corporate immunity to the COVID-19 pandemic? Evidence from China's stock market.
    Tian J; Wang X; Wei Y
    Front Public Health; 2022; 10():956521. PubMed ID: 36052006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Outbreak and Financial Performance of Chinese Listed Firms: Evidence From Corporate Culture and Corporate Social Responsibility.
    Sun Y; Li Y
    Front Public Health; 2021; 9():710743. PubMed ID: 34604155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do green supply chain management practices improve organizational resilience during the COVID-19 crisis? A survival analysis of global firms.
    Ullah M; Zahid M; All-E-Raza Rizvi SM; Qureshi QGM; Ali F
    Econ Lett; 2022 Oct; 219():110802. PubMed ID: 35990573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The financial impact of COVID-19: Evidence from an event study of global hospitality firms.
    Clark J; Mauck N; Pruitt SW
    Res Int Bus Finance; 2021 Dec; 58():101452. PubMed ID: 36540337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corporate immunity to the COVID-19 pandemic.
    Ding W; Levine R; Lin C; Xie W
    J financ econ; 2021 Aug; 141(2):802-830. PubMed ID: 34580557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The COVID-19 shock and the ownership of store Chain：Evidence from China's express delivery industry.
    Shang L; Liu Y; Xu P
    Heliyon; 2023 Oct; 9(10):e20799. PubMed ID: 37860577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will multi-industry supply chains' resilience under the impact of COVID-19 pandemic be different? A perspective from China's highway freight transport.
    Fu X; Qiang Y; Liu X; Jiang Y; Cui Z; Zhang D; Wang J
    Transp Policy (Oxf); 2022 Mar; 118():165-178. PubMed ID: 35125680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Threshold effects of energy consumption, technological innovation, and supply chain management on enterprise performance in China's manufacturing industry.
    Liu H; Fan L; Shao Z
    J Environ Manage; 2021 Dec; 300():113687. PubMed ID: 34530370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the impacts of COVID-19 outbreak on supply chain risks by modified failure mode and effects analysis: a case study in an automotive company.
    Ghadir AH; Vandchali HR; Fallah M; Tirkolaee EB
    Ann Oper Res; 2022 Mar; ():1-31. PubMed ID: 35378835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.